Related Experiment Video
Updated: Jul 14, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Host factors involved in the replication of hepatitis C virus
Kohji Moriishi1, Yoshiharu Matsuura
1Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Insights
Hepatitis C virus (HCV) chronic infection leads to liver cirrhosis and cancer. This review explores host proteins involved in HCV replication, offering insights for new chronic hepatitis C therapeutics.
Area of Science:
- Hepatology
- Virology
- Molecular Biology
Background:
- Hepatitis C virus (HCV) causes blood-borne hepatitis, often leading to chronic liver disease, cirrhosis, and hepatocellular carcinoma.
- Understanding HCV's life cycle, including entry, replication, and pathogenesis, is crucial for developing effective treatments.
- Recent advancements in HCV research include pseudotype viruses, in vitro replication systems, and autonomous RNA replication systems.
Purpose of the Study:
- To review current knowledge on host proteins that participate in Hepatitis C virus replication.
- To explore potential novel therapeutic interventions for chronic hepatitis C by targeting host-viral protein interactions.
Main Methods:
- Utilizing pseudotype viruses to identify viral receptor candidates.
- Employing an in vitro replication system of the HCV JFH1 strain.
- Investigating autonomous RNA replication systems based on artificial viral genomes.
Main Results:
- HCV replicates within an intracellular complex involving both viral and host proteins.
- Specific host proteins are essential for HCV replication and assembly.
- Inhibitors targeting host factors, such as cyclosporin A and sphingolipid synthesis inhibitors, demonstrate efficacy in blocking HCV replication.
Conclusions:
- Host proteins play a critical role in the Hepatitis C virus life cycle.
- Targeting the interplay between host and viral proteins presents a promising strategy for developing new anti-HCV therapeutics.
- Further research into host-viral interactions could lead to novel treatments for chronic hepatitis C.
Abstract:
Hepatitis C virus (HCV) is the major causative agent of blood-borne hepatitis. The majority of HCV-infected individuals develop chronic hepatitis, which eventually progresses to liver cirrhosis, and hepatocellular carcinoma. Although the precise mechanisms of entry, replication, assembly, egress and pathogenesis of HCV are largely unknown, information about viral receptor candidates has accumulated by the development of pseudotype viruses and an in vitro replication system of the HCV JFH1 strain. Furthermore, the autonomous RNA replication system based on the artificial viral genome revealed that HCV replicates in the intracellular replication complex composed of viral and host proteins. Recently, an immunosuppress ant, cyclosporin A and inhibitors for sphingolipid synthesis and chaperon were reported to inhibit the replication of HCV by counteracting the interplay between host and viral proteins. This review considers the current knowledge of the host proteins that participate in HCV replication and the possibility of developing novel therapeutics intervention for chronic hepatitis C.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Inhibitors Of Virion Release
Viruses with RNA Genomes
Retroviruses
Inhibitors of Virion Maturation and Assembly

